Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1991-03-05
1994-05-17
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514665, 514558, 5142388, 5142312, 562104, A01N 3752, C07C23900
Patent
active
053128397
ABSTRACT:
Compounds and a method useful for protection of tissue cells in a mammalian body from irreversible damages due to lactic acidosis caused by oxygen deficiency. The protection is achieved by administering a compound having a cell membrane permeability and/or ability to cross the blood brain barrier and being able to provide a buffering action to prevent an increase in a hydrogen ion concentration over the physiologically acceptable levels.
REFERENCES:
patent: 3943253 (1976-03-01), Barer et al.
Nakada, T. et al, "Intrauterine Fetal Brian NMR Spec . . . " Magn. Reson. Med., 12(2), 172-80, 1989.
Yorifuji, et al, "Gratuitous Introduction of 2-.omega.-Guanidino Acid Amidinohydrolases" Aug. 27, 1981 Department of Agricultural and Biological Chemistry, pp. 317-318.
A Comparison of Two Cerebral Perfusion Tracers, N-Isopropyl 1-123 p-Iodoamphetamine and 1-123 HIPDM, in the Human, Clinical Sciences, Investigative Nuclear Medicine, vol. 25, No. 1, pp. 25-30, 1984.
The Effect of Anaesthetics on the Uptake of Brian-imaging Agents in Rats, Nuclear Medicine Communications 6, 75-81 (1985), pp. 75-81.
N-Isopropyl-[.sup.123 I]p-Iodoamphetamine: Single-Pass Brain Uptake and Washout; Binding to Brain Synaptosomes; and Localization in Dog and Monkey Brain, The Journal of Nuclear Medicine, vol. 21, No. 10, pp. 947-952, 1980.
A New Brain Perfusion Imaging Agent: [I-123]HIPDM:N,N,N,-Trimethyl-N.sup.1 -[2-Hydroxy-3-Methyl-5-Iodobenzyl]-1,3 Propanediamine, The Journal of Nuclear Medicine, vol. 24, No. 1, pp. 66-72, 1983.
Development of 1-123-Labeled Amines for Brian Studies: Localization of 1-123 Iodophenylalkyl Amines in Rat Brain, Radiochemisty and Radiopharmaceuticals, The Journal of Nuclear Medicine, vol. 21, No. 10, pp. 940-945, 1980.
Regional Intracellular pH Shift: A Proposed New Mechanism for Radiopharmaceuitcal Uptake in Brain and Other Tissues, Preliminary Notes, The Journal of Nuclear Medicine, vol. 21, No. 2, pp. 147-152, 1980.
J. Rigandy, S. P. Klesney, Nomenclature of Organic Chemistry, IUPAC, p. 58, Pergamon Press, (1979).
N. Irving Sax, R. J. Lewis, Hawley Condensed Chemical Dictionary, p. 595, 11th Ed., Van Nostrand Reinhold Company, N.Y. (1987).
D. B. Guralnik, Webster's New World Dictionary, p. 920, 2nd College Ed., William Collins Publ., Inc., (1979).
T. Nakada, I. Kwee, S. Suzuki, and K. Houkin, Intrauterine Fetal Brain NMR Spectroscopy:.sup.1 H and .sup.31 P Studies in Rats Magnetic Resonance in Medicine 12: 172-180(1989).
Dees Jos,e G.
Dolezalova Hana
MacMillan Keith
Regents of the University of California
LandOfFree
Compounds and method for protection of cells and tissues from ir does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and method for protection of cells and tissues from ir, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and method for protection of cells and tissues from ir will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-877068